US CDC Continues Inquiry Into Potential Stroke Link from Pfizer, BioNTech Booster Shot



MT Newswires 2023

All news about PFIZER, INC.

Analyst Recommendations on PFIZER, INC.

Sales 2022 101 B
–
–
Net income 2022 33 059 M
–
–
Net cash 2022 3 150 M
–
–
P/E ratio 2022 7,58x
Yield 2022 3,65%
Capitalization 248 B
248 B
–
EV / Sales 2022 2,44x
EV / Sales 2023 3,14x
Nbr of Employees 79 000
Free-Float 59,0%



Duration :


Period :




Pfizer, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends PFIZER, INC.

Short Term Mid-Term Long Term
Trends Bearish Neutral Neutral

Income Statement Evolution

Sell

Buy

Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 44,25 $
Average target price 53,65 $
Spread / Average Target 21,2%




Source link

Ozinize
Logo
Shopping cart